Picture of Kezar Life Sciences logo

KZR — Kezar Life Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Kezar Life Sciences Says Preliminarily Estimates Its Cash, Cash Equivalents & Marketable Securities As Of Dec 31, 2021 Were About $208.4 Million

Jan 7 (Reuters) - Kezar Life Sciences Inc  KZR.O :
    * KEZAR LIFE SCIENCES - PRELIMINARILY ESTIMATES ITS CASH,
CASH
EQUIVALENTS & MARKETABLE SECURITIES AS OF DEC 31, 2021 WERE
ABOUT $208.4 MILLION

Source text for Eikon:  ID: 
Further company coverage:  KZR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kezar Life Sciences

See all news